- Home
- CORT vs DRS Comparison
CORT vs DRS Comparison
Compare CORT & DRS Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- CORT
- DRS
- Stock Information
- Founded
- CORT 1998
- DRS 1969
- Country
- CORT United States
- DRS United States
- Employees
- CORT N/A
- DRS N/A
- Industry
- CORT Biotechnology: Pharmaceutical Preparations
- DRS Military/Government/Technical
- Sector
- CORT Health Care
- DRS Industrials
- Exchange
- CORT Nasdaq
- DRS Nasdaq
- Market Cap
- CORT 7.5B
- DRS 11.8B
- IPO Year
- CORT N/A
- DRS N/A
- Fundamental
- Price
- CORT $71.72
- DRS $47.66
- Analyst Decision
- CORT Strong Buy
- DRS Strong Buy
- Analyst Count
- CORT 4
- DRS 7
- Target Price
- CORT $142.00
- DRS $43.57
- AVG Volume (30 Days)
- CORT 1.6M
- DRS 1.8M
- Earning Date
- CORT 07-28-2025
- DRS 07-30-2025
- Dividend Yield
- CORT N/A
- DRS 0.76%
- EPS Growth
- CORT 8.36
- DRS 25.90
- EPS
- CORT 1.14
- DRS 0.88
- Revenue
- CORT $685,446,000.00
- DRS $3,345,000,000.00
- Revenue This Year
- CORT $35.83
- DRS $9.96
- Revenue Next Year
- CORT $35.24
- DRS $6.50
- P/E Ratio
- CORT $62.92
- DRS $54.11
- Revenue Growth
- CORT 30.93
- DRS 13.58
- 52 Week Low
- CORT $30.77
- DRS $22.73
- 52 Week High
- CORT $117.33
- DRS $47.80
- Technical
- Relative Strength Index (RSI)
- CORT 50.50
- DRS 61.43
- Support Level
- CORT $66.49
- DRS $45.17
- Resistance Level
- CORT $72.49
- DRS $47.80
- Average True Range (ATR)
- CORT 2.85
- DRS 1.57
- MACD
- CORT -0.09
- DRS 0.06
- Stochastic Oscillator
- CORT 49.95
- DRS 93.06
About CORT Corcept Therapeutics Incorporated
Corcept Therapeutics Inc is a commercial-stage pharmaceutical company engaged in the discovery and development of medications that treat severe metabolic, oncologic and neuropsychiatric disorders by modulating the effect of the hormone cortisol. The company's compounds are being evaluated in clinical trials as potential treatments for a variety of serious disorders - hypercortisolism, advanced ovarian cancer, prostate cancer, ALS, and MASH.
About DRS Leonardo DRS Inc.
Leonardo DRS Inc is a provider of defense products and technologies that are used across land, air, sea, space, and cyber domains. The company is in the design, development, and manufacture of Advanced sensing, network computing, force protection, and electric power and propulsion technologies and solutions. The company has two segments: Advanced Sensing and Computing, which generates the majority of revenue, and the Integrated Mission Systems segment. The Advanced Sensing and Computing segment is engaged in designing, developing, and manufacturing sensing and network computing technology that enables real-time situational awareness required for enhanced operational decision-making and execution by the customers.